Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

308.08 +7.89 (+2.63%)
Official Closing Price Updated: 7:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Markets News for Tuesday
Oil stocks are up on huge gains. 
Via Talk Markets
Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders
Amgen Inc's (NASDAQ: AMGN) Q4 revenues incr 
Via Benzinga
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
The major indexes slashed weekly gains after Monday's follow-through day. 
Via Investor's Business Daily
Lilly's Covid Antibodies Drove A Big Beat, But Omicron Will Limit Sales
Eli Lilly reported $1.06 billion in fourth-quarter sales of its Covid antibodies. 
Via Investor's Business Daily
Eli Lilly: Q4 Earnings Insights
  Eli Lilly (NYSE:LLY) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:25 AM. Here's what investors need to know about the announcement. 
Via Benzinga
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit. 
Via InvestorPlace
Regeneron Scores Quarterly Beat On Covid Cocktail — But Future Sales Are Shaky
Regeneron posted 104% sales growth, including $2.3 billion from REGEN-COV. 
Via Investor's Business Daily
Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels
It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap... 
Via Talk Markets
Weakened Tech Stocks
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. 
Via Talk Markets
Eli Lilly Q4 Earnings Beat Estimates On Higher Demand For Trulicity, COVID-19 Therapies; Reaffirms FY22 Guidance
Eli Lilly And Co (NYSE: LLY) has  
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
Looking At Eli Lilly's Recent Whale Trades
Benzinga's options scanner just detected over 12 options trades for Eli Lilly (NYSE:LLY) summing a total amount of $597,272. At the same time, our algo caught 7 for a total amount of 518,954. 
Via Benzinga
Lilly To Inject $1B In New Manufacturing Facility In North Carolina, US
Eli Lilly And Co (NYSE: LLY)  
Via Benzinga
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
Eli Lilly And Co (NYSE: LLY) plans to invest more than €400 million into a new manufacturing facility in Limerick, Ireland, according to a 
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
A Preview Of Eli Lilly's Earnings
Eli Lilly (NYSE:LLY) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Eli Lilly will... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned. 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema
Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to  
Via Benzinga
What Are Whales Doing With Eli Lilly
A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 13 strange trades. If we... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade. The Dow Jones settled higher by around 100 points on Monday after tumbling more than 1,000 points... 
Via Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against the Omicron variant of COVID-19 and their... 
Via Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
The demand for monoclonal antibody treatments to help in the recovery of COVID-19 patients has outpaced the supply, and this situation runs the risk of becoming more acute as... 
Via Benzinga
Expert Ratings For Eli Lilly
Over the past 3 months, 7 analysts have published their opinion on Eli Lilly (NYSE: 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 12.31% on an annualized basis. Buying $1,000 In LLY: 5 years ago, an investor could have purchased 13.41... 
Via Benzinga
Week In Review: Mabwell Bio Raises $547 Million In Shanghai STAR IPO
Mabwell Bioscience completed a $547 million IPO on Shanghai's STAR Board. Abbisko Therapeutics formed a global collaboration worth up to $258 million with Lilly to continue discovery and development of... 
Via Talk Markets
Looking Into Eli Lilly and Company's Recent Short Interest
Eli Lilly and Company's (NYSE:LLY) short percent of float has risen 4.0% since last its last report. The company recently reported that it has 6.19 million shares sold short,... 
Via Benzinga
Looking At Eli Lilly's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 11 strange trades. If we... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
Upgrades According to Seaport Global, the prior rating for KB Home (NYSE: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.